Current Pneumonia News and Events

Current Pneumonia News and Events, Pneumonia News Articles.
Sort By: Most Relevant | Most Viewed
Page 1 of 25 | 1000 Results
COVID-19 warnings were on Twitter well before the outbreak of the pandemic
A new study of researchers at IMT School for Advanced Studies Lucca, published in Scientific Reports, has identified tracks of increasing concern about pneumonia cases on posts published on Twitter in seven countries, between the end of 2019 and the beginning of 2020. The analysis of the posts shows that the ''whistleblowing'' came precisely from the geographical regions where the primary outbreaks later developed. (2021-01-25)

ECMO/CRRT in the treatment of critically ill SARS-CoV-2 pneumonia patients
In a new publication from Cardiovascular Innovations and Applications; DOI https://doi.org/10.15212/CVIA.2019.1267, Hai Zou and Shengqing Li from the Institute of Pulmonary and Critical Care Medicine, Huashan Hospital, Fudan University, Shanghai, China consider ECMO/CRRT combined support in the treatment of critically ill SARS-CoV-2 pneumonia patients. (2021-01-22)

Study finds genetic clues to pneumonia risk and COVID-19 disparities
Researchers at Vanderbilt University Medical Center and colleagues have identified genetic factors that increase the risk for developing pneumonia and its severe, life-threatening consequences. (2021-01-21)

DNA test can quickly identify pneumonia in patients with severe COVID-19, aiding faster treatment
Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients. (2021-01-15)

Why COVID-19 pneumonia lasts longer, causes more damage than typical pneumonia
COVID pneumonia is significantly different from pneumonia caused by other causes, reports a new study in Nature. It shows how hijacks the lungs' own immune cells and uses them to spread across the lung over weeks. The infection leaves damage in its wake and fuels the fever, low blood pressure and damage to the kidneys, brain, heart and other organs in patients with COVID-19. Scientists discovered a target for treating COVID pneumonia and a clinical trial is underway at Northwestern. (2021-01-11)

Fatal health threat to young African children reduced by innovative artistic intervention
The fatal threat from diarrhoea and pneumonia to young children in the world's poorer countries can be drastically reduced by using traditional performing arts to encourage mothers to provide youngsters with safe food and water, a new study reveals. (2021-01-07)

Analysis of SARS-CoV-2 immune response several months post-infection hints at protective immunity
Researchers who studied antibody and immune cell responses in more than 180 men and women who had recovered from COVID-19 report these patients' immune memory to the virus - across all immune cell types studied - was measurable for up to 8 months after symptoms appeared. (2021-01-06)

State laws promoting flu vaccination for hospital workers may help prevent deaths from flu and pneum
Research suggests that state laws promoting influenza vaccination for hospital workers can be effective in preventing deaths from pneumonia and influenza, particularly among the elderly. Findings from a quasi-experimental observational study are published in Annals of Internal Medicine. (2021-01-04)

An explanation for the lack of blood oxygenation detected in many COVID-19 patients
Researchers at the Seville Institute of Biomedicine (IBIS) describe the presence in the human carotid body, the organ that senses oxygen in the blood, of the protein (ECA2) through which SARS-CoV-2 infects cells. (2020-12-29)

New study links cadmium to more severe flu, pneumonia infections
High levels of cadmium, a chemical found in cigarettes and in contaminated vegetables, are associated with higher death rates in patients with influenza or pneumonia--and may increase the severity of COVID-19 and other respiratory viruses, according to a new study. (2020-12-16)

How to stop infections caused by carbapenemase-producing bacteria
The authors aimed to evaluate in vivo the efficacy of imipenem plus meropenem in an experimental murine model of sepsis caused by clinical isolates of carbapenemase-producing A. baumannii. The results of this study show that the combination of imipenem plus meropenem could be effective in the treatment of infections caused by strains of carbapenemase-producing A. baumannii (OXA-23 and OXA-58). (2020-12-16)

Study uncovers two phases of infection in patients with severe COVID-19 pneumonia
To analyze SARS-CoV-2 at the tissue level, scientists examined lung specimens from 24 patients who succumbed to COVID-19. The analyses revealed two phases of infection in the patients: an early phase defined by high levels of virus in the lungs, and a later phase in which the virus is no longer present, but the damage to the lungs is too severe for recovery. (2020-12-16)

First 10 days after leaving hospital carry high risk for COVID-19 patients, study finds
In the first months after their COVID-19 hospital stay, patients face a high risk of ongoing health problems, hospital readmission and death, a growing number of studies shows. But the first week and a half may be especially dangerous, a new study finds. COVID-19 patients had a 40% to 60% higher risk of readmission or death in the first 10 days, compared with similar patients treated during the same months for heart failure or pneumonia. (2020-12-14)

Large US study confirms COVID-19 complications: lung, kidney and cardiovascular issues
A large study of patients in the United States who contracted coronavirus disease 2019 (COVID-19) confirms many complications of the disease, according to new research in CMAJ (Canadian Medical Association Journal). (2020-12-08)

Coronavirus pneumonia and pulmonary thromboembolism
Announcing a new publication for BIO Integration journal. In this article the authors Mingkang Yao; Phei Er Saw and Shanping Jiang from Sun Yat-Sen University, Guangzhou, China review Coronavirus Pneumonia and Pulmonary Thromboembolism. (2020-12-08)

Scientists shed new light on how lung bacteria defend against pneumonia
New insight on how bacteria in the lungs protect against invading pathogens has been published today in the open-access eLife journal. (2020-12-08)

New study explains important cause of fatal influenza
It is largely unknown why influenza infections lead to an increased risk of bacterial pneumonia. Researchers at Karolinska Institutet in Sweden have now described important findings leading to so-called superinfections, which claim many lives around the world every year. The study is published in the journal PNAS, Proceedings of the National Academy of Sciences, and can also contribute to research on COVID-19. (2020-11-25)

Fiji's vaccine program reduces childhood death and illness: study
Fiji's national vaccine program against pneumonia, a serious lung condition, and rotavirus, a common disease which causes severe diarrhoea and vomiting, has reduced illness and death, new research shows. (2020-11-25)

T-cell abnormalities in severe COVID-19 cases
There appears to be some kind of T cell abnormality in critically ill COVID-19 patients but specific details are unclear. To shed some light on the problem, researchers performed a genetic analysis of T cells from lung tissue of COVID-19 patients. They found abnormalities that resulted in T cell overreaction that may cause severe pneumonia. The research is expected to lead to new methods for avoiding severe pneumonia caused by coronavirus infections. (2020-11-20)

Just hours of training triples doctor confidence in use of handheld ultrasound devices
Filling a training gap, a Penn Medicine doctor created a geriatric medicine-centered course for point-of-care-ultrasound (POCUS) devices that doubled doctor confidence. (2020-11-17)

Effect of fluvoxamine vs placebo on clinical deterioration in outpatients with symptomatic COVID-19
This randomized trial compares the effects of fluvoxamine, a selective serotonin reuptake inhibitor with immunomodulatory effects, versus placebo on a composite of dyspnea or pneumonia and oxygen desaturation among adult outpatients with polymerase chain reaction-confirmed mild COVID-19 illness. (2020-11-12)

Mimicking SARS-CoV-2 nasal infection in monkeys
A new rhesus macaque animal model recapitulates the clinical and pathological manifestations of coronavirus disease 2019 (COVID-19) observed in humans by mimicking natural infection via the nasal route, according to a study published November 12 in the open-access journal PLOS Pathogens by Longding Liu, Qihan Li, Zhanlong He, and colleagues. As noted by the authors, the new animal model could lead to effective treatments or vaccines for COVID-19, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). (2020-11-12)

Electrical stimulation reduces swallowing problems in patients with neurological conditions
Using electrical stimulation in the throats of patients recovering from conditions such as strokes or head injuries will help to relieve swallowing problems, leading to a quicker recovery time, according to a new study. (2020-11-10)

Many with lupus at high risk for adverse reactions to pneumocystis pneumonia drug
New research shows that adults with systemic lupus erythematosus, who receive trimethoprim-sulfamethoxazole (TMP-SMX), a prophylactic therapy to help prevent pneumocystis pneumonia, are at high risk for adverse reactions to the drug, particularly if they are also positive for anti-Smith (anti-Sm) antibodies. Details of the study was presented at ACR Convergence, the American College of Rheumatology's annual meeting. (2020-11-06)

Amount of COVID viral RNA detected at hospital admission predicts how patients will fare
A new study published online in the Annals of the American Thoracic Society examines whether the amount of RNA, or genomic load, of SARS-CoV-2 detected in swab tests of patients being admitted to the hospital with viral pneumonia is associated with more severe COVID-19. SARS-CoV-2 is the virus that causes COVID-19. Previous studies on this question have had conflicting results. (2020-10-29)

Genetic analysis system yields new insights into bacterial pneumonia
A team of infectious disease researchers has developed a new method to identify virulence genes in Streptococcus pneumoniae, the leading cause of bacterial pneumonia. Using this technique in a mouse model of pneumonia, they were able to gain new insights into the progression of the disease and its interaction with the flu virus. (2020-10-28)

Tocilizumab doesn't ease symptoms or prevent death in moderately ill COVID-19 inpatients
The drug tocilizumab (Actemra) does not reduce the need for breathing assistance with mechanical ventilation or prevent death in moderately ill hospitalized patients with COVID-19, according to a study by researchers at Massachusetts General Hospital. The study, published in the New England Journal of Medicine, casts doubt on earlier research suggesting that tocilizumab, which is commonly prescribed for rheumatoid arthritis and other conditions, might be an effective treatment for patients with worsening cases of COVID-19. (2020-10-21)

Tocilizumab vs standard care on preventing worsening in patients hospitalized with COVID-19 pneumonia
Researchers in this randomized clinical trial compared the effect of early administration of tocilizumab with standard therapy in preventing clinical worsening in patients hospitalized with COVID-19 pneumonia. (2020-10-20)

Effect of tocilizumab in adults hospitalized with COVID-19 with moderate or severe pneumonia
This randomized clinical trial assessed whether tocilizumab improves outcomes of patients hospitalized with moderate-to-severe COVID-19 pneumonia compared to usual care. (2020-10-20)

The atomic makeup of M. pneumoniae's 'nap' structure glides into view
Using X-ray crystallography and cryo-electron microscopy, an international team of scientists unravel the atomic structure of the proteins P1 and P40/P90 which make up the ''Nap'' structure - a protein complex that the bacterium M. pneumoniae uses to attach and move around human cells to cause pneumonia. This will allow us to better understand the ''Nap'' structure and develop medicine and vaccines that stop the bacterium from infecting humans. (2020-10-14)

Study shows similar antibody response to key SARS-CoV-2 'spike' protein in COVID-19
New research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]) shows that antibody responses to related to the key 'spike' protein of the SARS-CoV-2 virus are similar in COVID-19 patients with and without diabetes, boosting hopes that vaccines involving this same protein will have a high chance of being as effective in vulnerable patients with diabetes as they will be in the general population. (2020-10-08)

Users of blood pressure medicine have a lower risk of dying from influenza and pneumonia
Thousands of Danes use ACE inhibitors or angiotensin II receptor blockers against elevated blood pressure or heart problems, and they may have an improved chance of surviving severe influenza or pneumonia infections. This is shown by a study from the Department of Clinical Epidemiology at Aarhus University and Aarhus University Hospital in Denmark. (2020-10-02)

People with Parkinson's disease have a higher risk of dying from COVID-19
A new database analysis of approximately 80,000 patients shows that people with Parkinson's disease (PD) have a 30% higher death rate from COVID-19 than people without the neurodegenerative condition. The new analysis of patient data in the TriNetX COVID-19 research network conducted by University of Iowa researchers and published in Movement Disorders suggests that Parkinson's disease is an independent risk factor for dying from COVID-19. (2020-10-01)

TGen and HonorHealth study suggests alternative method of diagnosing lung infection
As ventilator use in hospitals skyrockets during the COVID-19 pandemic, results of a study by the Translational Genomics Research Institute, City of Hope, HonorHealth Research and Innovation Institute, and the University of Arizona suggests a better way to diagnose ventilator-associated pneumonia (VAP). The findings of this study, which was supervised by Patrick Pirrotte, Ph.D., Director of TGen's Collaborative Center for Translational Mass Spectrometry, were published today in the scientific journal Molecular & Cellular Proteomics. (2020-10-01)

AI can detect COVID-19 in the lungs like a virtual physician, new study shows
A University of Central Florida researcher is part of a new study showing that artificial intelligence can be nearly as accurate as a physician in diagnosing COVID-19 in the lungs. The study, recently published in Nature Communications, shows the new technique can also overcome some of the challenges of current testing. (2020-09-30)

Twin studies suggest impaired type I interferon signaling may contribute to severe COVID-19 symptoms
Two new studies report specific mechanisms of impaired type I interferon (IFN) signaling in some hospitalized patients suffering from severe cases of COVID-19, suggesting that screens for these defects could help identify patients at the highest risk of life-threatening complications from SARS-CoV-2 infection. (2020-09-24)

Scientists Discover Genetic and Immunologic Underpinnings of Some Cases of Severe COVID-19
New findings by scientists at the National Institutes of Health and their collaborators help explain why some people with COVID-19 develop severe disease. The findings also may provide the first molecular explanation for why more men than women die from COVID-19. (2020-09-24)

Study on the effect of rosemary and ginger essential oils against Klebsiella pneumoniae
This study aims at investigating the antimicrobial and antibiofilm effect of rosemary and ginger essential oil-based nano-sized formulations on colistin resistant K. pneumonia clinical isolates. (2020-09-21)

Study shows one quarter of hospitalized young patients aged 18-39 years with COVID-19 developed pneumonia
New research to be presented at the ESCMID Conference on Coronavirus Disease (ECCVID, held online from 23-25 September) shows that one quarter of hospitalized younger patients with COVID-19 aged 18-39 years developed pneumonia, underlining the danger the disease represents to young people. (2020-09-17)

Vaccine proves effective against the most severe type of pneumonia
A pneumococcal vaccine was effective at protecting children in Laos against the most severe type of pneumonia, a new study has found. (2020-09-10)

Page 1 of 25 | 1000 Results
   First   Previous   Next      Last   
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.